MeVis Medical Solutions AG Reports First Half Fiscal Year 2023/2024 Results

Bremen, May 27, 2024 – MeVis Medical Solutions AG, a leader in medical imaging software, published its financial results for the first half of fiscal year 2023/2024, spanning from October 1, 2023, to March 31, 2024. The company reported revenues of €8,774k, compared to €8,472k in the previous year. Revenue composition remained stable with licenses contributing 27%, maintenance 35%, and other revenue 38%.

Earnings before interest and taxes (EBIT) increased from €1,893k to €2,735k, driven primarily by reduced expenses from currency translations. Earnings before taxes (EBT) matched EBIT figures this period. Interest income from loans to Varex Imaging Deutschland AG contributed €643k.

Income taxes amounted to €74k. Net income remained at €0k after considering the profit transfer to Varex Imaging Deutschland AG. The company maintains its forecast for the fiscal year, expecting sales to reach between €18.0m and €18.5m, with EBIT projected to remain stable at €4.5m to €5.0m.